Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus-A Prospect

Mar Drugs. 2017 Mar 23;15(4):88. doi: 10.3390/md15040088.

Abstract

An increasing prevalence of diabetes is known as a main risk for human health in the last future worldwide. There is limited evidence on the potential management of type 2 diabetes mellitus using bioactive peptides from marine organisms, besides from milk and beans. We summarized here recent advances in our understanding of the regulation of glucose metabolism using bioactive peptides from natural proteins, including regulation of insulin-regulated glucose metabolism, such as protection and reparation of pancreatic β-cells, enhancing glucose-stimulated insulin secretion and influencing the sensitivity of insulin and the signaling pathways, and inhibition of bioactive peptides to dipeptidyl peptidase IV, α-amylase and α-glucosidase activities. The present paper tried to understand the underlying mechanism involved and the structure characteristics of bioactive peptides responsible for its antidiabetic activities to prospect the utilization of rich marine organism proteins.

Keywords: bioactive peptide; glucose metabolism; marine protein; regulation; structure active relationship.

Publication types

  • Review

MeSH terms

  • Aquatic Organisms / chemistry*
  • Blood Glucose / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4 / chemistry
  • Dipeptidyl Peptidase 4 / pharmacology
  • Glucose / metabolism
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Insulin / metabolism
  • Peptides / chemistry
  • Peptides / pharmacology*
  • alpha-Amylases / chemistry
  • alpha-Amylases / pharmacology
  • alpha-Glucosidases / chemistry
  • alpha-Glucosidases / pharmacology

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Peptides
  • alpha-Amylases
  • alpha-Glucosidases
  • Dipeptidyl Peptidase 4
  • Glucose